Cite
HARVARD Citation
Isebia, K. et al. (2022). CABA-V7: a prospective biomarker selected trial of cabazitaxel treatment in AR-V7 positive prostate cancer patients. European journal of cancer. pp. 33-44. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Isebia, K. et al. (2022). CABA-V7: a prospective biomarker selected trial of cabazitaxel treatment in AR-V7 positive prostate cancer patients. European journal of cancer. pp. 33-44. [Online].